Die Zahl der Toten durch den Ebola-Ausbruch in der DR Kongo überschreitet die 3.000

The death toll from the ongoing Ebola outbreak in the Democratic Republic of Congo has surpassed 3,000, marking it as the deadliest such outbreak in history. According to the Congolese National Institute of Public Health, the virus has claimed 3,007 lives and infected 6,186 individuals as of Wednesday, September 2, 2026. The fatality rate stands at 48.6 percent, with 1,409 confirmed recoveries. The outbreak, which began in the remote northeastern province of Ituri, has since expanded into six provinces, all marked by weak governance and persistent violence. The spread of the virus has been exacerbated by multiple factors, including ongoing conflicts, attacks on healthcare workers, and the movement of miners who frequently travel across regions. Insecurity, fueled by the presence of armed groups, has further complicated containment efforts. Additionally, the reopening of schools during the outbreak has raised fears of increased transmission among students and staff. These challenges have overwhelmed local health systems, which lack both adequate resources and public trust in some communities. Health officials have noted that the Bundibugyo strain of Ebola, responsible for this outbreak, does not yet have an approved vaccine or specific treatment. While several experimental therapies are under evaluation, existing vaccines, such as Ervebo, are primarily effective against the Zaire strain, which was behind the 2014–2016 West African epidemic. The World Health Organization has endorsed a phase three clinical trial involving Ervebo, though its efficacy against the Bundibugyo strain remains uncertain. Initial findings suggest it might provide partial immunity, but definitive results are pending. Vaccination efforts have begun in Kisangani, the capital of Tshopo province, following the arrival of 16,250 doses of Ervebo for frontline medical workers. This marks a critical step in the global fight against the outbreak, even as uncertainties remain regarding the vaccine’s effectiveness against the current strain. The WHO has warned that the situation in the DRC could surpass the scale of previous outbreaks, with projections indicating the possibility of exceeding the 11,000 fatalities recorded during the West African crisis. The outbreak has placed immense pressure on local health infrastructure, which struggles to cope with the rapid rise in cases. Health workers face constant threats, including targeted attacks, which hinder their ability to respond effectively. The lack of a reliable vaccine and the absence of widespread community cooperation have compounded these difficulties. Despite these obstacles, international aid organizations continue to deploy resources and personnel to support containment measures. The virus, which spreads through direct contact with bodily fluids, causes severe hemorrhagic fever and can lead to multi-organ failure. Over the past five decades, it has claimed more than 15,000 lives across Africa. The current outbreak underscores the vulnerability of populations in regions affected by prolonged instability and limited access to healthcare. Efforts to control the spread rely heavily on surveillance, isolation protocols, and public awareness campaigns, all of which face significant logistical hurdles. As the situation continues to evolve, health authorities remain focused on expanding vaccination programs and improving coordination with local communities. The success of these initiatives will depend on overcoming deep-seated distrust and ensuring safe conditions for medical teams. With the number of infections continuing to climb, the race to contain the outbreak intensifies, demanding sustained international attention and support.